COVID-19
The Bureau of Customs-NAIA (BOC-NAIA) cleared 250,800 doses of the Moderna COVID-19 vaccine, developed by American drug firm Moderna, Inc., bringing the total number of Moderna doses to 250,800 since its first arrival on June 27, 2021. This batch of vaccines, the seventh to receive emergency use approval
COVID-19
Researchers from the University of Connecticut School of Medicine have conducted a comprehensive review of cutaneous side effects from mRNA COVID-19 vaccines, published in the journal Clinics in Dermatology. The study analyzed literature up to May 2021 and included data from the Centers for Disease Control and Prevention's
COVID-19
The European Union's temporary halt on recognizing Covishield COVID-19 vaccine, produced in India, as the same as AstraZeneca vaccine has raised concerns. However, the National Primary Health Care Development Agency (NPHCDA) has clarified that the ban is not permanent and that the process of validation for different vaccines
COVID-19
The global economy continued to send mixed signals as the ongoing COVID-19 pandemic persists, with varying outcomes in different regions. Key takeaways from top news stories this week include Johnson & Johnson's Covid vaccine showing strong immune response against the Delta variant, while Merck & Co's
COVID-19
Vaccine experts have issued a warning about the looming global health challenges posed by the current COVID-19 pandemic and seasonal influenza. New research from the University of North Carolina at Chapel Hill has shed light on the existing strategies for influenza vaccines and how they can inform the development of
COVID-19
The US Food and Drug Administration (FDA) plans to swiftly add a warning about rare cases of heart inflammation in adolescents and young adults to the fact sheets of COVID-19 vaccines from pharmaceutical companies Pfizer and Moderna. According to the US Centers for Disease Control and Prevention (CDC), the inflammation
COVID-19
As European countries continue to ease restrictions for vaccinated travelers, COVID-19 vaccines remain available for US military personnel and their beneficiaries across the US European Command (USEUCOM) area. The vaccines have proven to be effective in reducing the risk of severe illness, hospitalization, and death from COVID-19. With the infection
COVID-19
As India grapples with a catastrophic Covid-19 wave, its ambitions to become the "pharmacy of the world" are in tatters. The country's failure to secure enough vaccine shots has led to a de facto export ban, leaving its neighbors, including Nepal, Bangladesh, Bhutan, and Sri Lanka,
COVID-19
In a recent study published in The Lancet, researchers have found that two doses of the Pfizer-BioNTech vaccine offer 79% protection against the Delta COVID-19 coronavirus variant, while the Oxford-AstraZeneca vaccine provides 60% effectiveness. The study, conducted on 5.4 million people in Scotland, highlights the importance of getting both
COVID-19
Concerns over rare reports of heart inflammation in people who received the Pfizer and Moderna COVID-19 vaccines have led the U.S. Centers for Disease Control and Prevention to schedule an emergency meeting. The agency has identified 226 reports, most of which have recovered, but three remain in intensive care
COVID-19
Rutgers has announced that international students who have not been vaccinated can now receive the Pfizer, Moderna, or Johnson & Johnson vaccine upon entering the country. The University has expanded its vaccine policy to accept World Health Organization-approved vaccines for international students. This change comes after previously requiring all students
COVID-19
California has authorized the Pfizer vaccine for children between 12 and 15 years old, following a review of the U.S. Food and Drug Administration's approval by a group of experts from California and other Western states. This announcement has been welcomed by the California Academy of Family
